Goal hub

Anti-Aging & Cellular Longevity

Educational map of GH secretagogues, pineal cytogens, and dermal peptides used in longevity folklore. Telomerase and “youthful gene expression” are not a US anti-aging indication.

Full stacking map, tiers, and monitoring notes live on the protocol page — this hub only lists the compounds already named for this goal.

Open full protocolAll goals

Compounds on this goal

Epitalon

longevity

Khavinson tetrapeptide (AEDG). Telomerase and fibroblast papers exist from that group. Not a US anti-aging NDA. Independent replication is thin.

Open peptide leaf →

CJC-1295 (no DAC)

gh_secretagogue

GHRH analog used for pulsatile GH. No-DAC vs DAC is a different week. Not somatropin.

Open peptide leaf →

Ipamorelin

gh_secretagogue

Selective ghrelin receptor (GHS-R1a) agonist used with a GHRH analog. Cortisol/prolactin sparing vs GHRP-6 is the usual selling point, not a cleanliness ranking.

Open peptide leaf →

GHK-Cu

skin

Copper tripeptide with Pickart microarray papers. "4,000+ genes" is expression-array marketing, not a wrinkle RCT or a US reconstruction indication.

Open peptide leaf →

NAD+

longevity

NAD+ is a cofactor. IV or research vials are not a sirtuin-restoration NDA. Percent-decline slides are not a protocol.

Open peptide leaf →

NMN

mitochondrial

Oral NAD+ precursor identity. Not a peptide vial and not interchangeable with injectable NAD+ folklore on this hub.

Open peptide leaf →

Urolithin A

mitochondrial

Mitophagy metabolite sold as an oral longevity ingredient. Not MOTS-c, not SS-31, not reconstitution math.

Open peptide leaf →
Where to buyOral bioregulator

Oral bioregulator option

Epitalon itself isn't sold by Vita-Stream. For an oral, Khavinson-style course, its US-made Vita Peptides line has Vita Defender (thymus, adrenal, pituitary; supports immune and stress-response balance) and Vita Detox (liver, kidney, digestive; supports the body's natural detoxification processes).

Shop Vita DefenderShop Vita Detox

Use code KymataLabs at checkout

Affiliate link: Kymata Health earns a commission at no extra cost to you. Supplement statements have not been evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease. · Full review

Evidence note on this goal

Protocol evidence level (from existing goal data): Moderate

  • Epithalon data primarily from one group (Khavinson); independent replication limited
  • CJC-1295/Ipamorelin not FDA-approved; data from off-label clinical use
  • Long-term telomerase activation safety requires further study (theoretical cancer risk)
  • NAD+ delivery route significantly affects bioavailability; optimal method debated